Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis

R. K. Zeldin, Y. Amistani, J. Cognet-Sicé, K. Abiteboul (Antony, France)

Source: Annual Congress 2013 –Treatment of asthma
Session: Treatment of asthma
Session type: Thematic Poster Session
Number: 911
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. K. Zeldin, Y. Amistani, J. Cognet-Sicé, K. Abiteboul (Antony, France). Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis. Eur Respir J 2013; 42: Suppl. 57, 911

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013

Efficacy and safety of 300IR 5-grass pollen sublingual tablet in allergic patients with and without asthma
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012

Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

High doses of sublingual tablets of house dust mite allergen extracts: Lung function assessment in a phase I study in adults with mite-associated allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015


Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014


No increase in non-specific bronchial hyperreactivy in patients with cypress pollen allergy during the pollen season
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015


Effects of airborne pollen levels on drug consumption for seasonal allergic rhinoconjunctivitis: A ten-year French study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Efficacy of ruzam in the treatment of patients with perennial allergic rhinitis
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Unexpected severe systemic allergic reaction after hymenoptera sting in well controlled asthma during treatment with omalizumab
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Therapeutic effectpredictors during sublingual immunotherapy for Japanese seasonal allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Citizen science based symptom scores of allergic rhinitis to validate the grass pollen hay fever forecast
Source: International Congress 2015 – Indoor air and ambient pollution
Year: 2015

Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Skin prick test versus specific IgE – A comparative study in patients with bronchial asthma and allergic rhinitis in India
Source: International Congress 2014 – Clinical allergy
Year: 2014

Should patients with mild asthma be excluded from allergic rhinitis drug trials?
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015


Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 438s
Year: 2006

Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Collaborative treatment with variety of dust mites allergic in standardized dermatophagoides pteronyssinus allergen immunotherapy
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016